Gb Sciences Inc's

• GBLX's Stock Performance relative to its Competitors

Groove Botanicals Inc Share Performance -18.87% One Year

Groove Botanicals Inc Profile Groove Botanicals Inc is a company that operates on a direct-to-consumer model, offering a variety of botanical products through their online platform. They aim to provide high-quality and natural products directly to customers, cutting out traditional retail channels. More about Groove Botanicals Inc 's Market Share

Aurora Cannabis Inc Share Performance +9.82% Over The Past 5 Days

Aurora Cannabis Inc Profile Aurora Cannabis Inc operates as a vertically integrated cannabis company, controlling every aspect of the supply chain from cultivation to distribution. They focus on producing and selling medical and recreational cannabis products globally. This business model allows them to have greater control over product quality, streamline operations, and capitalize on the growing market for cannabis. More about Aurora Cannabis Inc 's Market Share

Axim Biotechnologies Inc Share Performance -32.00% One Year

Axim Biotechnologies Inc Profile Axim Biotechnologies Inc's business model revolves around developing and commercializing innovative pharmaceutical and nutraceutical products, primarily focusing on cannabinoid-based therapies. More about Axim Biotechnologies Inc 's Market Share

Canopy Growth Corporation Share Performance -26.79% One Year

Canopy Growth Corporation Profile Canopy Growth Corporation's business model revolves around being a leading producer and distributor of cannabis products, including both medicinal and recreational cannabis. The company focuses on cultivating, processing, and manufacturing various cannabis-based products, such as dried flowers, oils, and edibles. Canopy Growth Corporation also aims to expand its market presence through strategic partnerships and acquisitions, both domestically and internationally. More about Canopy Growth Corporation's Market Share

Corbus Pharmaceuticals Holdings Inc Share Performance +12.86% Over The Past 5 Days

Corbus Pharmaceuticals Holdings Inc Profile Corbus Pharmaceuticals Holdings Inc is a biopharmaceutical company focused on the development and commercialization of innovative therapies for inflammatory and fibrotic diseases. Their business model revolves around conducting research and clinical trials to identify potential drug candidates, obtaining regulatory approvals, and subsequently commercializing these drugs to generate revenue. They aim to address unmet medical needs by creating and marketing novel treatments for diseases such as systemic sclerosis, cystic fibrosis, and other inflammatory conditions. More about Corbus Pharmaceuticals Holdings Inc 's Market Share

Sources: Gb Sciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Thursday, September 17, 2026 9:34 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Gb Sciences Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.